Impact of the 12-gene recurrence score in influencing adjuvant chemotherapy prescription in mismatch repair proficient stage II/III colonic carcinoma—a systematic review and meta-analysis

INTRODUCTION: The 12-gene recurrence score (RS) is a clinically validated assay which predicts recurrence risk in patients with stage II/III colon cancer. Decisions regarding adjuvant chemotherapy may be guided using this assay or based on the judgement of tumour board. AIMS: To assess the concordan...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, Matthew G., O’Neill, Maeve, Regan, Mark, Meshkat, Babak, Nugent, Emmeline, Joyce, Myles, Hogan, Aisling M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011316/
https://www.ncbi.nlm.nih.gov/pubmed/36912973
http://dx.doi.org/10.1007/s00384-023-04364-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011316/
https://www.ncbi.nlm.nih.gov/pubmed/36912973
http://dx.doi.org/10.1007/s00384-023-04364-2

Ejemplares similares